SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Medical Industries Of America, MIOA

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tadsamillionaire who wrote (566)9/8/1999 10:52:00 AM
From: myelin2   of 570
 
That's what i waited for so long ... we will be rewarded with a ten bagger within the next 18 months i.m.o.

Taylor Stuart Financial Initiates Coverage on CyberCare, Inc. with
a Strong Buy Recommendation

LONG ISLAND, N.Y., Sept. 8 /PRNewswire/ -- The following was issued today by Taylor Stuart Financial, a member of the
NASD; CRD # 39025:

Taylor Stuart Financial today releases its research report on CyberCare, Inc. (OTC Bulletin Board: CYBR - news) with a
strong buy recommendation in a 3-page research report entitled ``Fundamentals Support Current Valuation: 'Strong Buy.'

"STRONG BUY"

SHARES OUTSTANDING: 35,000,000

MARKET CAP 40,000,000 (approx. 1x revenues)

PROJECTED 1999 REVENUES $40,000,000 (without CyberCare subsidiary)

PROJECTED 2000 REVENUES $65,000,000 (without CyberCare subsidiary)

PROJECTED 2001 REVENUES $100,000,000 (without CyberCare subsidiary)

CyberCare, Inc.'s (CYBR) corporate mission is to become the premier source for comprehensive medical and e-commerce
services, which will enable efficient interactions among providers, payors and patients.

CURRENT CORE BUSINESS:
-- Dynamic provider of diversified medical services - Southeastern United
States.
-- 45 rehabilitation centers providing:
Physical and pain rehabilitation
Occupation and speech therapy
Sleep apnea
-- Institutional pharmaceutical services, concentration on adult living
care facilities
-- Proposed e-commerce pharmaceutical site early 2000
-- Largest air ambulance response company in the world with over 17 jets,
servicing all of North America with previous service to China,
Australia, Hawaii, Canada, Latin America, Europe and Africa

CLINICAL e-COMMERCE ACQUISITION
-- August 26, 1999 acquired Atlanta based CyberCare, Inc. and changed name
accordingly.
-- Baseline technologies were developed by Georgia Tech and the Medical
College of Georgia in cooperation w/ the US army and licensed
exclusively to CyberCare, Inc.
-- Interactive Internet-based platform for remote monitoring of patients
and delivery of care and education
-- Portable computer-based system called the Personal Care Management
System (PCMS)

OPINION:

CyberCare is the future of ``First Contact, First Detection' Healthcare Services for the chronically ill/critical care (c/c)
patient. Critical Care (c/c) patients are those who need constant doctor/nurse visits provided by the healthcare payer at
approximately $70,000 per year per patient. Critical Care patients make up the majority of the 1-% of the population
responsible for approximately 30% of the $100 billion spent annually on Americans enrolled in a managed healthcare
program. These costs are due to repeated cycling through the healthcare system and include emergency room visits, frequent
doctor/nurse visits, and a disproportionate share of the medical resources provided to any managed healthcare subscriber.

CyberCare holds the license and recently received ``Notice of Allowance' for 19 claims submitted to the United States Patent
Office for Healthcare Internet Technology that allows doctors and nurses to monitor chronically ill patients from remote
locations via transmission over the Internet. Important data (vital signs) such as blood pressure, temperature, and pulse, ECG
and blood oxygen levels among others are gathered and transmitted on a portable computer-based system called the Personal
Care Management System (PCMS),

The PCMS platform provides two way interactive audio and video between doctors, nurses and support groups for the
chronically ill. The ability to monitor thousands of patients at a central care site will provide enormous savings to the
healthcare payers. The savings will be results of early detection of deterioration of the chronically ill patient prior to the need
for emergency room visits; short-term hospital stays, convalescent homes and adult care living facilities.

The PCMS platform will initially sell for $7500.00 per machine with a profit margin of approximately 40%. CyberCare
originally budgeted sales of 600 machines in their initial roll-out but have expressed the possibility of many more machines due
to the extremely high concentration of c/c patients as well as the elderly and frail in the state of Florida. There are
approximately 2.5 million c/c patients excluding the elderly and the frail whose healthcare providers are forced to spend
enormous amounts of money in the monitoring of their condition as well as the treatments. Should PCMS technology gain 1%
of the 2.5 million c/c patient market, this could translate into several hundred million dollars in additional revenue as well as
earnings of $1.00 plus per share over the next 18-36 months.

STRATEGIC ALLIANCES:
-- Strategic relationship with NORTEL Networks, Inc. for joint marketing
of CyberCare's homecare solutions throughout North America
-- Exclusive technology license from Georgia Tech and right of first
refusal for all future tele-homecare technologies developed by Georgia
Tech

COMPARABLE MEDICAL e-COMMERCE COMPANIES

MARKET CAPITALIZATION
-- CyberCare, Inc. $40 million
-- Mediconsult.com $390 million
-- Healtheon $6 billion

CONCLUSION:

We rate ``CYBR' a strong buy both in the near term as well as for the long term. The potential for PCMS technology is
limitless in an aging society committed to managed healthcare. CyberCare's plans to expand its Internet pharmaceutical
business from institutional only servicing adult living care facilities to full blown e-Commerce in early year 2000 offers an
additional spoke to the CyberCare wheel.

Our short term price target (3-6 months) $3-1/2
Our long term price target (12-24 months) $7-$10

All investments involve risk. The risk inherent in a particular security may not be appropriate for you. Please consult with your
Taylor Stuart Financial executive to obtain assistance in selecting appropriate investments.

This report is published for informational purposes only and is not to be considered as an offer or the solicitation of an offer to
sell or buy the security. The information contained herein is based on sources that we believe to be reliable, but we make no
guarantee or representation about the completeness of the statements or summaries of available data contained herein. This
information is provided as of the date of this report and is subject to change without notice. Furthermore, the information in
this report should be considered outdated 90 days after publication, or such earlier date as circumstances may require, and
should not be relied upon thereafter to develop investment strategies. Taylor Stuart does not currently make a market in the
securities of CyberCare, Inc. Taylor Stuart's principals, employee and clients may currently own shares of the securites of
CyberCare. Taylor Stuart has acted as a consultant/investment banker to Medical Industries of America prior to its name
change to CyberCare, Inc.

Taylor Stuart is a member of the NASD, SIPC.

SOURCE: Taylor Stuart Financial
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext